GlassScriptPhysician profile
Sohail Moussavi
NPI 1265521611
$5,199.96
in general payments reported to CMS, 2019-2025
44 companies · $946 in 2025
The $946 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $889 · 2020: $409 · 2021: $758 · 2022: $348 · 2023: $928 · 2024: $922 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,783 · Entertainment: $13.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,782.62 |
| Entertainment | $13.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $918.50 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $612.59 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $532.76 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $419.59 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $267.98 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $249.82 | 2019-2025 | |
| Amgen INC. | $215.77 | 2019-2025 | Repatha, Otezla, Repatha |
| Boston Scientific Corporation | $184.44 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor, Bodyguardian |
| Astellas Pharma US INC | $136.90 | 2019-2024 | Veozah |
| Merck Sharp & Dohme LLC | $135.31 | 2019-2024 | Capvaxive, Dificid |
| Medtronic Vascular, INC. | $114.09 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $113.30 | 2019-2025 | Eliquis |
| Sanofi-Aventis U.S. LLC | $104.59 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.30 | 2022-2025 | |
| Exact Sciences Corporation | $99.21 | 2023-2025 | Cologuard Collection Kit |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohail Moussavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.